Skip to main content
. 2019 Jun 17;179(9):1176–1185. doi: 10.1001/jamainternmed.2019.1051

Figure 2. Association Between Hospital Risk-Standardized Echocardiography Rates and Nuclear Imaging and Angiotensin-Converting Enzyme Inhibitor (ACEi) or Angiotensin Receptor Blocker (ARB) Use.

Figure 2.

A, Hospital rates of echocardiography use and hospital rates of nuclear imaging. B, Hospital use rate of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.